Penetration of Bevacizumab through the Retina after Intravitreal Injection in the Monkey

Abstract
Purpose. The penetration of intravitreally injected bevacizumab in its commercial formulation (Avastin; Roche, Grenzach, Germany) through the retina was studied, to determine whether a full-length antibody would be able to penetrate the retina as easily as an antibody fragment.

This publication has 0 references indexed in Scilit: